Home » Topics » BioWorld Science

BioWorld Science
RSS

The enteropeptidase inhibitor SCO-792 enters phase II development

Nov. 29, 2019

GSK-3527497, a new preclinical candidate for effective inhibition of TRPV4

Nov. 29, 2019

NMPA approves flumatinib mesylate for the treatment of Ph+ chronic myeloid leukemia

Nov. 29, 2019

Gilead Sciences is enrolling participants in phase II study of GS-4875

Nov. 29, 2019

Bionomics presents Nav1.7 channel blockers

Nov. 29, 2019

New anticancer compounds discovered at Zymeworks

Nov. 29, 2019

Incyte patents PD-1/PD-L1 interaction inhibitors

Nov. 29, 2019

Array BioPharma, Mirati Therapeutics describe new G12C-mutant GTPase KRAS inhibitors

Nov. 29, 2019

Prestige Biopharma initiates phase III study of proposed biosimilar HD-204

Nov. 29, 2019

First-in-human study of 89Zr-DFO-REGN-3504 for imaging PD-L1 tumors

Nov. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...